Dopamine and drug addiction: the nucleus accumbens shell connection.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing animal neurochemistry, intracranial self-administration, and human brain imaging studies.
PubMed 15464140 · doi:10.1016/j.neuropharm.2004.06.032
What was done
This narrative review synthesized evidence from animal microdialysis, intracranial self-administration, conditioned taste avoidance (CTA) assays, and human neuroimaging studies to evaluate the role of nucleus accumbens (NAc) shell dopamine transmission in drug reward and Pavlovian learning.
What was found
The abstract reports no quantitative statistical metrics. Addictive drugs preferentially elevate extracellular dopamine in the NAc shell. In humans, striatal dopamine increases correlate with self-reported euphoria and drug liking. In animal models, D2 or combined D1/D2 receptor blockade abolishes cocaine-, amphetamine-, and nicotine-induced CTA. Intracranial self-administration of mixed D1/D2 agonists identifies the NAc shell as critical for dopamine-mediated reward. Unlike natural rewards such as food, drug-induced NAc shell dopamine transmission fails to undergo habituation or inhibition by predictive cues, leading to abnormal dopamine responsiveness to drug-conditioned stimuli.
Why it matters
It provides a mechanistic framework distinguishing how addictive substances hijack normal reward learning pathways in the NAc shell, explaining why drug-associated cues maintain unusually persistent control over behavior.
Limits
The abstract presents a theoretical synthesis without reporting sample sizes, study selection criteria, or quantitative effect sizes. The conclusions rely heavily on rodent neurochemical and behavioral models with limited direct human experimental verification.
Cited by
- context In mice, sex increases dopamine release by 100%, whereas amphetamines increase dopamine release by 1,000%.